BNGO
Price
$3.37
Change
-$0.38 (-10.13%)
Updated
Apr 3, 04:51 PM (EDT)
Capitalization
57.43M
MBOT
Price
$1.57
Change
-$0.12 (-7.06%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
18.57M
40 days until earnings call
Ad is loading...

BNGO vs MBOT

Header iconBNGO vs MBOT Comparison
Open Charts BNGO vs MBOTBanner chart's image
Bionano Genomics
Price$3.37
Change-$0.38 (-10.13%)
Volume$100
Capitalization57.43M
Microbot Medical
Price$1.57
Change-$0.12 (-7.06%)
Volume$800
Capitalization18.57M
BNGO vs MBOT Comparison Chart
Loading...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNGO vs. MBOT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a Buy and MBOT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BNGO: $3.75 vs. MBOT: $1.70)
Brand notoriety: BNGO and MBOT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BNGO: 127% vs. MBOT: 73%
Market capitalization -- BNGO: $57.43M vs. MBOT: $18.57M
BNGO [@Medical Specialties] is valued at $57.43M. MBOT’s [@Medical Specialties] market capitalization is $18.57M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNGO’s FA Score shows that 1 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • BNGO’s FA Score: 1 green, 4 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, MBOT is a better buy in the long-term than BNGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNGO’s TA Score shows that 4 TA indicator(s) are bullish while MBOT’s TA Score has 4 bullish TA indicator(s).

  • BNGO’s TA Score: 4 bullish, 3 bearish.
  • MBOT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BNGO is a better buy in the short-term than MBOT.

Price Growth

BNGO (@Medical Specialties) experienced а +20.19% price change this week, while MBOT (@Medical Specialties) price change was +11.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.32%. For the same industry, the average monthly price growth was +1.69%, and the average quarterly price growth was +1.51%.

Reported Earning Dates

BNGO is expected to report earnings on Nov 09, 2023.

MBOT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (-4.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNGO($57.4M) has a higher market cap than MBOT($18.6M). MBOT YTD gains are higher at: 51.786 vs. BNGO (-78.329). MBOT has higher annual earnings (EBITDA): -10.75M vs. BNGO (-213.4M). BNGO has more cash in the bank: 102M vs. MBOT (8.15M). MBOT has less debt than BNGO: MBOT (245K) vs BNGO (79.4M). BNGO has higher revenues than MBOT: BNGO (36.1M) vs MBOT (0).
BNGOMBOTBNGO / MBOT
Capitalization57.4M18.6M309%
EBITDA-213.4M-10.75M1,985%
Gain YTD-78.32951.786-151%
P/E RatioN/AN/A-
Revenue36.1M0-
Total Cash102M8.15M1,251%
Total Debt79.4M245K32,408%
FUNDAMENTALS RATINGS
BNGO vs MBOT: Fundamental Ratings
BNGO
MBOT
OUTLOOK RATING
1..100
318
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
9738
P/E GROWTH RATING
1..100
87100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for MBOT (57). This means that BNGO’s stock grew somewhat faster than MBOT’s over the last 12 months.

BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MBOT (100). This means that BNGO’s stock grew similarly to MBOT’s over the last 12 months.

BNGO's SMR Rating (99) in the Biotechnology industry is in the same range as MBOT (99). This means that BNGO’s stock grew similarly to MBOT’s over the last 12 months.

MBOT's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for BNGO (97). This means that MBOT’s stock grew somewhat faster than BNGO’s over the last 12 months.

BNGO's P/E Growth Rating (87) in the Biotechnology industry is in the same range as MBOT (100). This means that BNGO’s stock grew similarly to MBOT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNGOMBOT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 17 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLPH0.580.05
+10.00%
Talphera
DH2.790.15
+5.68%
Definitive Healthcare Corp
DSGN3.790.18
+5.13%
Design Therapeutics
CVI19.540.32
+1.66%
CVR Energy
TU13.99-0.38
-2.64%
Telus Corp